Dugan Margaret
SEC Form 4 insider trading activity
Dugan Margaret has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including ONC, WHWK, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Dugan Margaret is listed as Director at BeOne Medicines Ltd. Inside the rolling window, Dugan Margaret reported no open-market purchases and 1 open-market sale totaling $66K in ONC.
Companies traded
Other insiders at ONC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 16, 2025 | SDGR | Sale | $29K |
Frequently asked questions
How many SEC Form 4 filings has Dugan Margaret made?
Dugan Margaret has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including ONC, WHWK since 2025.
Which companies does Dugan Margaret trade?
Dugan Margaret has filed SEC Form 4 disclosures for 2 companies, including ONC, WHWK.
When was Dugan Margaret's most recent SEC Form 4 filing?
Dugan Margaret's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Dugan Margaret's total buy and sell value in the current window?
Inside the rolling retention window, Dugan Margaret bought $0 and sold $66K based on SEC Form 4 filings.
What was Dugan Margaret's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 212 ONC shares on 2026-05-22, worth $66K, per SEC Form 4 filings.